Our findings indicate a significant association between education level, comorbidity, nutritional status, blood IL-6 level, the combination of drugs, medication literacy and various skin ADRs in NSCLC patients undergoing targeted EGFR-TKI therapy. This evidence concerns the gene EGFR and non-small cell lung carcinoma.